Skip to main content

Table 5 Antibacterial activity of tedizolid against MRSA isolates based on year groups

From: Antibacterial activity of recently approved antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) strains: A systematic review and meta-analysis

Tedizolid

 

MIC50

MIC90

MIC50/90

Susceptibility rate (%)

2010–2015

Median

0.25

0.5

1

100

Min.

0.25

0.25

1

99.7

Max.

0.5

1

2

100

2016–2020

Median

0.25

0.5

1.2

100

Min.

0.12

0.12

1

99.6

Max.

0.5

0.5

2

100